Recent developments in the Canadian market, such as a decline in unemployment and easing inflation, suggest a cautiously optimistic economic outlook. In this context, penny stocks—typically representing smaller or newer companies—offer unique opportunities for growth at lower price points. Despite their somewhat outdated name, these stocks can provide significant potential when backed by strong financials and solid fundamentals.
Top 10 Penny Stocks In Canada
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Westbridge Renewable Energy (TSXV:WEB) |
CA$1.88 |
CA$47.27M |
★★★★★★ |
| Cannara Biotech (TSXV:LOVE) |
CA$1.82 |
CA$177.81M |
★★★★★★ |
| Zoomd Technologies (TSXV:ZOMD) |
CA$0.95 |
CA$94.75M |
★★★★★★ |
| Montero Mining and Exploration (TSXV:MON) |
CA$0.76 |
CA$6.35M |
★★★★★★ |
| CEMATRIX (TSX:CEMX) |
CA$0.355 |
CA$53.94M |
★★★★★★ |
| Monument Mining (TSXV:MMY) |
CA$1.11 |
CA$400.68M |
★★★★★★ |
| Thor Explorations (TSXV:THX) |
CA$1.52 |
CA$1.03B |
★★★★★★ |
| Pulse Seismic (TSX:PSD) |
CA$3.80 |
CA$194.24M |
★★★★★★ |
| Caldwell Partners International (TSX:CWL) |
CA$0.96 |
CA$28.34M |
★★★★★★ |
| Hemisphere Energy (TSXV:HME) |
CA$2.17 |
CA$200.93M |
★★★★★★ |
Click here to see the full list of 359 stocks from our TSX Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Pharmala Biotech Holdings
Simply Wall St Financial Health Rating:★★★★☆☆
Overview:Pharmala Biotech Holdings Inc. is a biotechnology company focused on the development, manufacture, and sale of MDMA and MDXX class molecules for clinical research purposes, with a market cap of CA$10.34 million.
Operations:The company generates CA$0.75 million in revenue from the development and sale of MDMA and MDXX class molecules for clinical research purposes.
Market Cap:CA$10.34M
Pharmala Biotech Holdings Inc., a pre-revenue biotechnology company with a market cap of CA$10.34 million, is focused on developing MDMA and MDXX class molecules for clinical research. Despite its lack of profitability and short cash runway, the company maintains a debt-free balance sheet with assets exceeding liabilities. Recent changes in the board bring seasoned financial expertise with the appointment of Lennie Ryer, CPA, CA. However, auditors have expressed concerns about its ability to continue as a going concern. Pharmala has engaged in strategic agreements to supply clinical research materials to institutions like Ostfold Hospital Trust and Orygen Institute.
BIGG Digital Assets
Simply Wall St Financial Health Rating:★★★★★☆
Overview:BIGG Digital Assets Inc. is involved in owning, operating, and investing in digital asset businesses across Canada, the USA, Europe, and internationally with a market cap of CA$21.35 million.
Operations:The company's revenue is primarily generated from Canada (CA$11.68 million), followed by the USA (CA$1.11 million) and Europe (CA$0.42 million).
Market Cap:CA$21.35M
BIGG Digital Assets Inc., with a market cap of CA$21.35 million, has shown revenue growth, reporting CA$3.29 million in the third quarter of 2025 compared to CA$2.13 million a year ago. Despite being unprofitable and having a negative return on equity (-92.35%), the company benefits from experienced management and board teams with average tenures of 3.9 and 6.2 years respectively. Its short-term assets (CA$265 million) comfortably cover both short-term (CA$254.8 million) and long-term liabilities (CA$4,200). BIGG remains debt-free but is not expected to achieve profitability within the next three years.
Westbridge Renewable Energy
Simply Wall St Financial Health Rating:★★★★★★
Overview:Westbridge Renewable Energy Corp. focuses on acquiring and developing solar photovoltaic projects across Canada, the United States, the United Kingdom, and Italy, with a market cap of CA$47.27 million.
Operations:There are no reported revenue segments for Westbridge Renewable Energy Corp.
Market Cap:CA$47.27M
Westbridge Renewable Energy Corp., with a market cap of CA$47.27 million, is pre-revenue but offers potential through its international solar and battery energy storage projects. Recent approvals for the Red Willow and Dolcy projects in Alberta highlight progress towards operational capacity, with Dolcy moving to the 'Ready-to-Build' stage. The company trades at a significant discount to its estimated fair value and benefits from an experienced management team. Despite negative earnings growth last year, Westbridge's debt-free status and strong insider retention position it as an intriguing prospect within renewable energy development sectors.
Make It Happen
-
Navigate through the entire inventory of 359 TSX Penny Stocks here.
-
Interested In Other Possibilities? The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CNSX:MDMA TSXV:BIGG and TSXV:WEB.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
